Please login to the form below

Not currently logged in
Email:
Password:

Zafatek

This page shows the latest Zafatek news and features for those working in and with pharma, biotech and healthcare.

Merck drops once-weekly diabetes drug in US and EU

Merck drops once-weekly diabetes drug in US and EU

It was not the first weekly DPP-4 inhibitor to reach the market, however, having been pipped to the post in Japan by Takeda's rival drug Zafatek (trelagliptin succinate), which

Latest news

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

Data desires
What are you looking to achieve with data and how are you preparing yourself to react to the results?...
The balancing act that’s keeping pharma and biotech market access on its toes
Pricing drugs and gaining reimbursement can be a real challenge for drug developers. Price it too high, and no one buys it. Price it too low, and it’s hard to...
Pills
Tackling antimicrobial resistance on multiple fronts
An urgent change of direction is needed in how we respond to AMR...

Infographics